Objectives: Given the conflicting definitions of "generalized osteoarthritis" (GOA) in the literature, we performed a systematic review of GOA definitions, risk factors, and outcomes. Methods: We searched the MEDLINE literature with the terms osteoarthritis, generalized, polyarticular, multiple joint, and multi-joint to obtain articles related to GOA, following evidence-based guidelines. Titles and abstracts of 948 articles were reviewed, with full-text review of 108. Data were extracted based on pre-specified criteria for 74 articles plus 24 identified through bibliographic review (n ¼ 98). Results: Twenty-four large cohorts (n 30,000) were represented along with numerous clinical series (n 9000), across 22 countries and 60 years . No less than 15 definitions of GOA were given in 30 studies with a stated GOA definition; at least 6 groups used a summed score of joints or radiographic grades. Prevalence estimates based on these GOA definitions were 1-80%, although most were 5-25%. Increased risk and progression of GOA was associated with age, female sex, and genetic/ familial factors. Associations with increased body mass index or bone mineral density were not consistent. A study estimated the heritability of GOA at 42%. Collagen biomarker levels increased with the number of involved joints. Increased OA burden was associated with increased mortality and disability, poorer health, and function.
Introduction
Generalized osteoarthritis (GOA) is a term that is widely used in the literature in an attempt to describe the often polyarticular nature of osteoarthritis (OA). Polyarticular involvement in OA was described as early as the mid-1800s (although this report also included descriptions of inflammatory arthritis) [1] , followed by a description of "chronic degenerative polyarthritis" of menopause in 1926 [2] , and the first clearly recognizable description of GOA in 1952 [3] . Unfortunately, to date, there is no clear, consistent definition for what actually constitutes GOA, and numerous alternative terms are used (e.g., polyarticular OA, multi-joint or multiple joint OA, or lists of affected joints). A reference often cited as a definition of GOA (Lawrence [4] ) actually explores 2 definitions (3 or more and 5 or more joints). Although it remains clear that multiple joints are commonly involved in OA, the definition of the term GOA itself remains vague at best, and misleading at worst, since this term cannot be understood in the absence of a clearly stated definition by the authors, which may or may not be provided.
To examine the strengths and limitations of current definitions of GOA and the associations between GOA and risk factors and outcomes, we reviewed the literature reporting on multiple joint involvement in OA since 1946 to form a systematic summary of the work to date. Through this effort, we hope to identify difficulties and weaknesses with the current body of literature and to suggest ways to improve the study of polyarticular involvement in OA, which we view as an important consideration in ongoing research that so often focuses on single joint sites in isolation. n Corresponding author at: Thurston Arthritis Research Center, University of
Methods
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and with the assistance of a professional research librarian, we performed a MEDLINE (1946 to present) search first on March 23, 2011 and updated on September 25, 2012 for articles related to GOA (osteoarthritis, osteoarthrosis, degenerative joint disease, generalized, polyarticular, global, nodal, multiple joint, multi-joint, etc.) and published in a clinical journal, limited to English-language articles in human adults (age 19 years and up, see Table 1 for full search details). Given the lack of standardized terminology, we limited our search to MEDLINE to obtain the most relevant articles. Initial inclusion criteria were a focus on OA and assessment of more than one joint site. Two coauthors (A.E.N. and M.W.S.) performed an independent review of the identified abstracts, and disagreements between reviewers were resolved by consensus. The full-text articles were then reviewed by 2 coauthors (A.E.N. and Y.M.G.) to determine which would be carried forward to data extraction. Exclusion criteria were (1) lack of a clear definition of OA (any of radiographic, symptomatic, clinical, and self-report) or (2) failure to report on more than one distant joint site (multiple joints within a single site, such as multiple hand joints or tibiofemoral and patellofemoral alone, was not sufficient). Again, disagreements were resolved by consensus. Additionally, one author (A.E.N.) reviewed the bibliographies for all articles at the full-text review step and identified further relevant articles that were also included for data extraction. One author (A.E.N.) performed data extraction using an Excel sheet containing categories agreed upon by all the authors. Extracted data included general study characteristics (first author, publication year, study years, country, parent study, and study type); OA-related characteristics (type of OA assessment, joint sites assessed, criteria for OA diagnosis, risk factors, and outcomes considered); population characteristics (number of participants, age range, percentage of female, race/ethnic groups considered, and body mass index); and results (joint sites affected, associations between joints, definitions of GOA, risk factors associated with GOA, and outcomes assessed in GOA). Given the descriptive nature of this review, which spans many years and various study types and does not focus on trials of interventions, no assessment of study quality or risk of bias was performed. Similarly, due to the variety of reported risk factors and outcomes, data were not combined and we did not perform any statistical analyses.
Results

Search and articles
After removal of duplicates, the MEDLINE search resulted in a total of 948 citations [855 on March 23, 2011 (Table 1) and an additional 93 on September 25, 2012 using an identical search strategy]. An additional 28 citations were identified through hand searching of bibliographies. Of 976 total articles, 840 were excluded based on title and abstract review, leaving 136 for fulltext review. Thirty-eight articles were excluded at this step (agreement was 85%, others were adjudicated) due to either lack of a clear definition of OA or failure to assess more than one joint site, leaving 98 articles for data extraction (Fig.) .
In the 98 included articles, 24 unique large cohorts were represented (n ¼ 30,223), along with numerous clinical series (n ¼ 9252), across 22 countries, spanning 5 continents (North America, Europe, Africa, Asia, and Australia), and 60 years (1952-2012, Table 2 ).
Joint sites
The joint sites assessed varied widely but most often included the hands and knees. Radiographic and/or clinical definitions of OA were most often cited, although the radiographic scales varied (Kellgren-Lawrence grades were most often used), as did the clinical definitions (the American College of Rheumatology definitions [5] [6] [7] were most commonly cited). In some reports, only clinically abnormal or reportedly symptomatic joints underwent radiography, while in others a specified set of joints was examined in all participants. In 30 studies, where a definition of GOA was clearly stated, no less than 15 definitions of GOA were given ( Table 3 ). The interphalangeal joints of the hands were essentially always included in GOA definitions, but there appeared to be little agreement as to the appropriateness or necessity of including other joints such as the hip, spine, and feet. Among the 18 studies from Table 3 explicitly stating which joints were considered, 100% included the hands, 16/18 included the knees, 12/18 included the hips, and 7/18 assessed the spine (any level) or feet.
Other studies assessed multiple joint sites but did not propose a GOA definition. Several of these were supportive of GOA as a construct (supporting the constitutional/systemic nature of OA) [8] [9] [10] [11] [12] [13] [14] [15] [16] , while others were skeptical [17] or found little support for such a construct [18] . It is very difficult and potentially misleading to assess prevalence of GOA given the variability of definitions, joint sites, and populations (varied by setting, gender, age, race, etc.) assessed. Reported estimates of the frequency of such variably defined GOA ranged from 1% to 80%, although in most that were not selected for OA status, estimates were in the 5-25% range.
Associated factors
Studies were focused primarily on the patterns of OA involvement, although a variety of risk factors and outcomes were considered in the literature. Most studies were in Caucasian populations, but a few assessed racial differences. Nodal changes and hip OA were infrequent among African-descent populations compared with British [19] [20] [21] . Chinese individuals had a similar frequency of DIP involvement compared to British, but they had a low frequency of OA at other joint sites [8] . African American women compared with Caucasian women had a higher frequency of MCP and knee OA and their combination [22] . In another study, African American men and women were less likely than Caucasians to have hand OA but more likely to have knee OA [16] . That multiple joint OA is more common in women compared with men was confirmed in several studies [4, 16, [23] [24] [25] [26] [27] [28] .
Increased frequency of GOA or higher risk of GOA progression was associated with age in nearly all studies. Evidence of genetic/ familial risk factors was reported [29] [30] [31] [32] [33] [34] [35] [36] . Some studies reported associations between elevated body mass index and other measures of body mass and multiple joint OA [22, 37, 38] , but this finding was not consistent [39, 40] . A higher bone mineral density was seen in GOA patients in some series [41] , but this association was either equivocal [42, 43] or not seen in other work [44] . A study estimated the heritability of GOA at 42% [30] . Smoking was noted to be possibly protective for GOA [45] [46] [47] , but again, it was not consistently seen across studies [22] . Increased OA burden was associated with poorer function and quality of life and increased disability [10, 26, 28, 48, 49] .
At least 8 studies from 6 research groups used a summed score to capture OA at multiple sites, generally to allow correlations with systemic markers, such as bone mass, cytokines, OA biomarkers, or genetic markers. These included summed radiographic grades [44, 50] and sums of numbers of affected joints or joint groups [30, 36, 45, [51] [52] [53] . Cerhan et al. [51] reported associations between the number of joints with OA, number of joint groups with OA, and a binary definition of GOA (3 or more joints with K-L grade of 2 or higher) and survival time. Joint counts correlated with levels of putative OA biomarkers, including urinary type II collagen C-telopeptide (uCTX-II) [52] , cartilage oligomeric matrix protein (COMP) [54, 55] , YKL 40 (human cartilage glycoprotein 39) [56] , matrix metalloproteinase-3 (MMP-3) [57] , and hyaluronic acid [58] , but not with inflammatory markers, such as adiponectin, C-reactive protein, or tumor necrosis factor [53, 58] .
Discussion
This systematic review provides the first comprehensive summary of the literature to date assessing multiple joint involvement in OA. A detailed search with many synonyms was performed given the lack of standardized terminology in this area. Our hope is that this work will serve as a reference, in order to inform future studies, with the goal of encouraging more research in this area. It seems clear from the results above that a higher burden of OA is associated with poorer outcomes, with the suggestion that multiple joint OA may be a marker of more severe disease that may show increased progression. It is also possible that those with multiple joint OA may benefit more from systemic therapies than would those with single joint/localized OA. However, it is also clear that there is a lack of not only a clear consensus definition for research but also a widely understood clinical construct for GOA.
Generally, 2 groups of similar, although not entirely consistent, definitions emerged: (1) multiple hand joint OA and (2) hand with large joint OA. Multiple hand joint OA, which was reported mostly in descriptive articles, was defined as 3 or more hand joints or as 3 or more specifically IP joints, with or without Heberden nodes, and in some definitions, bilateral distribution was required. Hand with large joint (knee and/or hip) OA usually included DIP or CMC joints with knee or hip joints. In the first group (multiple hand joints), Doherty et al. [24] described greater frequency and severity of radiographic and symptomatic knee OA in patients 19 years or more after unilateral meniscectomy among patients with concomitant polyarticular hand OA vs those without, independent of sex and age, and for both operated and unoperated knees. Another group assessed nodal GOA (nodes þ at least 3 IP joints) in comparison with large joint OA (hip or knee) or controls and found more frequent immunoglobulin (Ig) G rheumatoid factor positivity among nodal GOA (51%) vs large joint OA (17%) or controls (11%, p o 0.0001), with no differences for IgA or IgM rheumatoid factor positivity [59] . Nodal GOA patients more frequently had low IgA levels (23%) compared to those with large joint OA (14%) or controls (6%) [59] . Associations have also been reported between multiple joint hand GOA and estrogen receptor genotype [31] and elevated MMP-3 levels [57] . The second group, utilizing a definition of GOA that includes the hand and large joint OA, includes several studies from the Ulm and GARP cohorts. The Ulm study included individuals scheduled for unilateral hip (n ¼ 420) or knee (n ¼ 389) joint replacement, and defined GOA as OA involvement in at least 1 CMC joint, at least 2 IP joints (DIP or PIP), in addition to the involved hip or knee [27] . Eighty-two percent of hip OA and 87% of knee OA patients had involvement of the contralateral joint, and 27% had GOA. GOA was more frequent in knee OA patients (35%) compared with hip OA patients (19%) but the prevalence was similar in these 2 groups after accounting for age and sex variation. GOA was about twice as common in women compared to men, and it was more frequent with increasing age [27] . Other analyses using this cohort have found that overweight (27%) or obese (29%) individuals were more likely to have GOA compared with normal weight (24%, although not statistically significant) [39] ; those in the highest tertile of serum uric acid were more likely to have GOA in the hip OA group [adjusted OR (aOR) ¼ 3. [61] . Other groups using a similar definition have found a possible protective effect of smoking for GOA [46] and no association with vitamin D receptor phenotype [62] . Interestingly, in a post-mortem skeletal study, Waldron [25] defined GOA in the same way and also found that all individuals meeting those criteria also had shoulder OA.
The GARP study defined GOA as radiographic involvement of multiple hand joints or 2 of 4 total sites (of hands, cervical or lumbar spine, knee, and hip) with at least one symptomatic site. GOA was positively associated with being married vs unmarried (aOR ¼ 2.0, 95% CI: 1.3-3.3), having had menopause before the age of 45 years vs 45-52 years (aOR ¼ 2.6, 95% CI: 1.5-4.5), with hysterectomy and ovariectomy (aOR ¼ 1.5-1.8), and with overweight and obesity (aOR ¼ 1.9-2.1) [47] . GOA was negatively associated with smoking (aOR ¼ 0.7, 95% CI: 0.4-1.0) and was less prevalent in those over 180 cm vs under 160 cm in height [47] . Physically demanding jobs were associated with GOA among men only (for men aOR ¼ 2.5, 95% CI: 1.2-5.3; for women aOR ¼ 1.3, 95% CI: 0.6-2.8) [47] . Each of the joint areas studied in GARP, with the exception of disc degeneration, contributed to higher levels of uCTX-II, and a significant association was found between uCTX-II levels and a composite summed score of radiographic OA at multiple sites (estimate 0.06, 95% CI: 0.04-0.07) [52] . Kornaat et al. [63] used data from the first 42 GARP patients along with 27 age-and sex-matched controls and found that GOA patients had higher popliteal vessel wall thickness compared to controls, suggesting an association between GOA and the metabolic syndrome. Min et al. [33] used data from GARP and a similar GOA definition in the Rotterdam study to assess genetic associations with the frizzled-related protein gene (part of the Wnt pathway), finding that the G allele of the R324G variant was more common in GOA in both populations (aOR ¼ 1.4-1.6). Overall, the studies included in this review have several limitations as a group, including vague definitions of GOA or related constructs. It was often unclear exactly which joints or joint groups were considered in a given study, and whether these were the same for all participants; some studies assessed only symptomatic joints which varied among individuals. Variation in assessed joints across studies, even when specified, makes comparison of risk factors and outcomes difficult. In some cases, misclassification bias due to differential assessment in cases and controls was a concern. Several studies were of radiographic OA alone, without consideration of symptomatic or clinical factors. Study participants were often recruited based on pain in a signal joint, such that the generalizability to other groups or the general population was uncertain.
The strengths of this systematic review include our use of a professional research librarian, adherence to the PRISMA guidelines, and dual independent reviews of both abstracts and full-text articles with adjudication. We were admittedly limited by the lack of appropriate medical subject heading (MeSH) terms and the disparate terminology in the literature on this topic, and in part because of this we were unable to perform any statistical or metaanalysis.
Future research should focus on defining phenotypes of multiple joint involvement of OA to determine if more homogeneous groups may exist. Such phenotypes, if identified, could be used as outcomes for studies of systemic risk factors such as genetics and biomarkers, and possibly in clinical trials, particularly of systemic therapies. Focused trials in well-defined subgroups thought to be at higher risk for incidence or progression of OA could result in shorter, less-expensive trials of promising OA treatments (both pharmacologic and non-pharmacologic). It will also be important for future trials in OA to account for symptoms in multiple joints, even if a signal joint is the therapeutic focus, since benefit or harm could potentially be observed at distant joint sites (e.g., the adverse events observed in the shoulder, ankle, and foot for patients enrolled in tanezumab studies for hip and knee OA [64] ).
Conclusion
We feel, based on the lack of clear definitions identified in this study, that the term GOA should be discarded in favor of more specific and understandable terms, such as multiple joint or polyarticular OA, which must be accompanied in every case by an unambiguous statement as to the joints considered and the construct being used. Further study is needed to determine appropriate phenotypes for clinical and research use.
